Table 1.
Effect of supplementation on the biochemical serum profile levels during posttest assessment.
| Parameter | Placebo | NCE | p-value |
|---|---|---|---|
| AST (U/L) | 16.4 ± 0.4 | 15.6 ± 0.3 | 0.1590 |
| ALT (U/L) | 9.5 ± 0.3 | 6.1 ± 0.5∗ | 0.0002 |
| ALP (U/L) | 89.4 ± 5.3 | 63.8 ± 2.3∗ | 0.0013 |
| LDH (U/L) | 176.4 ± 4.07 | 176.4 ± 4.01 | 0.9991 |
| CK (U/L) | 73.6 ± 6.5 | 63.7 ± 3.6 | 0.2136 |
| Albumin (g/L) | 45.6 ± 0.2 | 45.7 ± 0.3 | 0.6469 |
| TP (g/L) | 74.5 ± 0.8 | 74.9 ± 0.8 | 0.7461 |
| BUN (mmol/L) | 13.1 ± 0.2 | 12.4 ± 0.4 | 0.1253 |
| UA (mmol/L) | 4.8 ± 0.1 | 4.9 ± 0.1 | 0.3051 |
| Glucose (mg/dL) | 77.6 ± 1.8 | 78.4 ± 1.8 | 0.7744 |
| TC (mg/dL) | 164± 6 | 153 ± 7 | 0.2411 |
| TG (mg/dL) | 82 ± 4 | 56 ± 4∗ | 0.0006 |
| HDL (mg/dL) | 48 ± 1 | 57 ± 2∗ | 0.0017 |
| LDL (mg/dL) | 105 ± 10 | 86 ± 6 | 0.1450 |
Data are mean ± SEM and n = 6 subjects/group. The asterisk (∗) in the same row indicates a significant difference at p<0.05 by One-Way ANOVA. AST: aspartate aminotransferase; ALT: alanine aminotransferase; ALP: alkaline phosphatase; LDH: lactic dehydrogenase; CK: creatine kinase; TP: total protein; BUN: blood urea nitrogen; UA: uric acid; TC: total cholesterol; TG: triglycerides; HDL: high-density lipoprotein; LDL: low-density lipoprotein